Previous close | 67.70 |
Open | 69.00 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 69.00 - 69.00 |
52-week range | 45.12 - 87.00 |
Volume | |
Avg. volume | 5,417 |
Market cap | N/A |
Beta (5Y monthly) | 1.21 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
FIRST QUARTER (JANUARY - MARCH 2024)
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy.
RaySearch Laboratories AB (publ) is proud to announce the continued commitment with Mevion Medical Systems, the leading global provider of compact proton therapy solutions, to develop new proton therapy solutions in support of current and emerging technologies. Together RaySearch and Mevion re-imagine novel solutions to advance the use of new proton therapy technologies and empower medical providers to rapidly and efficiently bring next-generation proton therapy services to their patients.